Näytä suppeat kuvailutiedot

dc.contributor.authorPlaza‐Florido, Abel
dc.contributor.authorOlvera‐Rojas, Marcos
dc.contributor.authorAlcantara, Juan M. A.
dc.contributor.authorRadom‐Aizik, Shlomit
dc.contributor.authorOrtega, Francisco B.
dc.date.accessioned2024-06-19T07:41:43Z
dc.date.available2024-06-19T07:41:43Z
dc.date.issued2024
dc.identifier.citationPlaza‐Florido, A., Olvera‐Rojas, M., Alcantara, J. M. A., Radom‐Aizik, S., & Ortega, F. B. (2024). Targeted proteomics involved in cardiovascular health and heart rate variability in children with overweight/obesity. <i>American Journal of Human Biology</i>, <i>Early online</i>. <a href="https://doi.org/10.1002/ajhb.24113" target="_blank">https://doi.org/10.1002/ajhb.24113</a>
dc.identifier.otherCONVID_220713810
dc.identifier.urihttps://jyx.jyu.fi/handle/123456789/96008
dc.description.abstractBackground Children with overweight/obesity often exhibit alterations in their plasma protein profiles and reduced heart rate variability (HRV). Plasma proteomics is at the forefront of identifying biomarkers for various clinical conditions. We aimed to examine the association between plasma-targeted proteomics involved in cardiovascular health and resting vagal-related HRV parameters in children with overweight/obesity. Methods Forty-four children with overweight/obesity (10.2 ± 1.1 years old; 52% boys) participated in the study. Olink's technology was used to quantify 92 proteins involved in cardiovascular health. HRV was measured using a heart rate monitor (Polar RS800CX). Four resting vagal-related HRV parameters were derived in time- and frequency-domain. Results Eight proteins (KIM1, IgG Fc receptor II-b, IDUA, BOC, IL1RL2, TNFRSF11A, VSIG2, and TF) were associated with at least one out of the four vagal-related HRV parameters (β values ranging from −0.188 to 0.288; all p < .05), while KIM1, IDUA, and BOC associated with ≥ three vagal-related HRV parameters. Multiple hypothesis testing corrections did not reach statistical significance (false discovery rate [FDR >0.05]). Conclusion Plasma-targeted proteomics suggested novel biomarkers for resting vagal-related HRV parameters in children with overweight/obesity. Future studies using larger cohorts and longitudinal designs should confirm our findings and their potential clinical implications.en
dc.format.mimetypeapplication/pdf
dc.language.isoeng
dc.publisherWiley
dc.relation.ispartofseriesAmerican Journal of Human Biology
dc.rightsCC BY-NC 4.0
dc.titleTargeted proteomics involved in cardiovascular health and heart rate variability in children with overweight/obesity
dc.typeresearch article
dc.identifier.urnURN:NBN:fi:jyu-202406194774
dc.contributor.laitosLiikuntatieteellinen tiedekuntafi
dc.contributor.laitosFaculty of Sport and Health Sciencesen
dc.type.urihttp://purl.org/eprint/type/JournalArticle
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1
dc.description.reviewstatuspeerReviewed
dc.relation.issn1042-0533
dc.relation.volumeEarly online
dc.type.versionpublishedVersion
dc.rights.copyright© 2024 the Authors
dc.rights.accesslevelopenAccessfi
dc.type.publicationarticle
dc.subject.ysobiomarkkerit
dc.subject.ysosyke
dc.subject.ysolapset (ikäryhmät)
dc.subject.ysosydän- ja verisuonitaudit
dc.subject.ysolihavuus
dc.subject.ysoylipaino
dc.subject.ysoproteomiikka
dc.subject.ysoveriplasma
dc.subject.ysoleposyke
dc.subject.ysoproteiinit
dc.format.contentfulltext
jyx.subject.urihttp://www.yso.fi/onto/yso/p12288
jyx.subject.urihttp://www.yso.fi/onto/yso/p3751
jyx.subject.urihttp://www.yso.fi/onto/yso/p4354
jyx.subject.urihttp://www.yso.fi/onto/yso/p9886
jyx.subject.urihttp://www.yso.fi/onto/yso/p823
jyx.subject.urihttp://www.yso.fi/onto/yso/p826
jyx.subject.urihttp://www.yso.fi/onto/yso/p7548
jyx.subject.urihttp://www.yso.fi/onto/yso/p22516
jyx.subject.urihttp://www.yso.fi/onto/yso/p27966
jyx.subject.urihttp://www.yso.fi/onto/yso/p4332
dc.rights.urlhttps://creativecommons.org/licenses/by-nc/4.0/
dc.relation.doi10.1002/ajhb.24113
jyx.fundinginformationThe project was mainly funded by the Spanish Ministry of Economy and Competitiveness (Reference DEP2013-47540, DEP2016-79512-R, and DEP2017-91544-EXP) and by the Andalusian Operational Programme supported with European Regional Development Funds (ERDF in English, FEDER in Spanish, projects ref: B-CTS-355-UGR18 and A-CTS-614-UGR20) and Junta de Andalucia (P20_00158). A.P.F. is supported by PERC Systems Biology Fund. MO-R. is supported by the Spanish Ministry of Science, Innovation and Universities (FPU 22/02476). Additional support was obtained from the Unit of Excellence on EXERNET Research Network on Exercise and Health (DEP2005- 00046/ACTI; 09/UPB/19; 45/UPB/20; 27/UPB/21). This study has been partially funded by the University of Granada, Plan Propio de Investigación 2016, Excellence actions: Units of Excellence; Unit of Excellence on Exercise and Health (UCEES), and by the Junta de Andalucía, Consejería de Conocimiento, Investigación y Universidades and European Regional Development Fund (ERDF), ref. SOMM17/6107/UGR. J.M.A.A. is supported by the grant FJC2020-044453-I funded by MCIN/AEI/10.13039/501100011033 and by “European Union NextGenerationEU/PRTR” and Universidad de Granada/CBUA.
dc.type.okmA1


Aineistoon kuuluvat tiedostot

Thumbnail

Aineisto kuuluu seuraaviin kokoelmiin

Näytä suppeat kuvailutiedot

CC BY-NC 4.0
Ellei muuten mainita, aineiston lisenssi on CC BY-NC 4.0